BSN medical is a global medical device company - and one of the world's leading suppliers in the product segments of casting, bandaging, traditional wound care and compression therapy.
Several of our well-known brands – Gypsona®, Orthoglass®, JOBST®, Radiante®, Delta-Cast®, Tricodur® and Leukoplast® – are among the most trusted names in the healthcare profession.
BSN medical has production facilities in Germany, Colombia, France, Mexico, Pakistan, South Africa and the U.S, operating all over the world via affiliates, joint ventures and distribution agents. We employ more than 3,400 people and have generated revenues of €605 million in 2009.
Background
BSN was established in April 2001 as a 50:50 joint venture between Beiersdorf AG, Hamburg, and Smith & Nephew plc, London due to complemtary geographic and channel strengths in the areas of wound care, fracture management, physiotherapy and compression therapy.
Then functioning as an independent player, BSN was aquired by Montagu Private Equity firm in early 2006, a leading private equity investor in the European mid-market with offices in London, Manchester, Paris, Düsseldorf and Stockholm. Over the last 38 years, the firm has supported more than 400 businesses operating across a range of different segments and sectors, and currently has more than €3 billion under management.
The General Management Committee includes:
Dr. Claus-H. Wiegel, Chief Executive
Emil Billbaeck, Group Director Marketing and Innovation
Steve Brown, Chief Financial Officer
Andreas Hogrefe, Group Director Europe
Steve Jay, Group Director Human Resources
Darrell Jenkins, Group Director Operations and President Americas
Ann Maitland, Sr. Vice President Operations
